By the end of 2017, CTS has secured three source plasma partners and continues to seek additional partners in the plasma industry in order to continue to diversify CTS’s revenue stream.
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...